Compare Align Technology, Inc. (ALGN) vs US Bancorp (USB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs US Bancorp — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while US Bancorp trades at $62.61 (market cap $97.22B). The key difference: US Bancorp is far larger — about 7.6× Align Technology, Inc.'s market cap, and US Bancorp pays a 3.33% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | USB | |
|---|---|---|
Market Cap | $12.86B | $97.22B |
Sector | Health | Financials |
52-Week High | $207.19 | $62.89 |
52-Week Low | $124.88 | $43.94 |
Enterprise Value | $11.92B | — |
Dividend Yield | — | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
U.S. Bancorp (USB) trades at $62.41, up 0.82% with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals with three consecutive quarterly earnings beats, a P/E of 13.08, and net income margin of 27.04%. Recent developments include the launch of Enhanced Payments for small businesses and a planned dividend increase following successful stress test results.
The outlook remains positive with analyst consensus targeting $67.00 (7.4% upside). Key opportunities include sustained earnings growth and dividend reliability, while risks involve negative cash flow trends and rising debt-to-asset ratios. The stock presents a balanced risk-reward profile for value-oriented investors seeking financial sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
